{"id":"W4205118722","doi":"10.1200/jco.2021.39.15_suppl.3564","title":"LEAP-005: A phase 2 multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the colorectal cancer cohort.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Lenvatinib; Medicine; Pembrolizumab; Irinotecan; Internal medicine; Colorectal cancer; Oncology; Clinical endpoint; Response Evaluation Criteria in Solid Tumors; Cancer; Oxaliplatin; Phases of clinical research; Clinical trial; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003266943,0.002078451,0.00188998,0.0005808588,0.0006284845,0.001215055,0.0009852824,0.00114379,0.004331054],"category_scores_gemma":[0.001339957,0.0008926853,0.001676518,0.0004837716,0.001040472,0.001123673,0.0007137583,0.002278917,0.00114419],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001244999,"about_ca_system_score_gemma":0.001808007,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001379576,"about_ca_topic_score_gemma":0.002236105,"domain_scores_codex":[0.9990237,0.0005275,0.00004828244,0.000173598,0.00008043549,0.000146653],"domain_scores_gemma":[0.9987751,0.0001620873,0.0002441529,0.0001252596,0.00007282336,0.0006204696],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8630955,0.06214866,0.02657261,0.0004050657,0.002820041,0.0003388133,0.0002594886,0.001003086,0.01637021,0.0001067324,0.002176587,0.02470307],"study_design_scores_gemma":[0.5064363,0.4223157,0.06176628,0.00003087571,0.00181434,0.0005759961,0.0001493849,0.001094871,0.002438654,0.0001383921,0.003177356,0.0000619067],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952462,0.000718975,0.0003105392,0.0001329099,0.00006126523,0.001871581,0.001124168,0.00004301452,0.0004913307],"genre_scores_gemma":[0.9901724,0.0006497298,0.001088609,0.000554889,0.0001958906,0.002390102,0.00323334,0.00002803177,0.001686971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004331054,"threshold_uncertainty_score":0.01727748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06010222905887123,"score_gpt":0.4302120549211831,"score_spread":0.3701098258623118,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}